AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Earnings & Estimates
NASDAQ:AMPH - US03209R1032 - Common Stock
30.26 USD
-0.23 (-0.75%)
30.5 USD
+0.24 (+0.79%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 499M 13.98% | 644.395M 29.14% | 731.967M 13.59% | 739.72M 1.06% | 791.98M 7.06% | 829.77M 4.77% | 863.94M 4.12% | 920.04M 6.49% | 965.94M 4.99% | 1.001B 3.63% | 1.028B 2.70% | |
| EBITDA YoY % growth | 132.74M 42.14% | 241.464M 81.91% | 262.624M 8.76% | 254.36M -3.15% | 279.37M 9.83% | 285.87M 2.33% | 331.93M 16.11% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 107.5M 53.79% | 199.687M 85.76% | 205.419M 2.87% | 219.64M 6.92% | 246.26M 12.12% | 265.08M 7.64% | 255M -3.80% | 276.42M 8.40% | 295.8M 7.01% | 311.1M 5.17% | 321.3M 3.28% | |
| Operating Margin | 21.54% | 30.99% | 28.06% | 29.69% | 31.09% | 31.95% | 29.52% | 30.04% | 30.62% | 31.08% | 31.25% | |
| EPS YoY % growth | 1.97 44.85% | 3.30 67.51% | 3.86 16.97% | 3.41 -11.62% | 3.85 12.99% | 4.20 8.87% | 3.75 -10.55% | 3.96 5.43% | 4.09 3.35% | 4.16 1.75% | 4.13 -0.74% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.87 -9.33% | 0.93 1.58% | 0.77 3.38% | 0.85 0.20% | 0.90 3.71% | 0.89 -5.04% |
| Revenue Q2Q % growth | 190.21M -0.53% | 197.56M 5.92% | 179.52M 5.27% | 185.64M 6.44% | 191.76M 0.81% | 194.72M -1.44% |
| EBITDA Q2Q % growth | 64.357M -35.38% | 68.468M -33.10% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 56.263M -1.38% | 59.792M 32.45% | 48.756M 30.74% | 52.53M 24.53% | 58.038M 3.15% | 59.466M -0.55% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.85 -9.57% | 0.76 | 0.09 | 12.46% |
| Q1 2025 Q2Q % growth | 0.74 -28.85% | 0.70 | 0.04 | 5.65% |
| Q4 2024 Q2Q % growth | 0.92 4.55% | 0.96 | -0.04 | -4.55% |
| Q3 2024 Q2Q % growth | 0.96 -16.52% | 1.01 | -0.05 | -4.74% |
| Q2 2024 Q2Q % growth | 0.94 44.62% | 0.79 | 0.15 | 19.17% |
| Q1 2024 Q2Q % growth | 1.04 67.74% | 0.98 | 0.06 | 6.52% |
| Q4 2023 Q2Q % growth | 0.88 20.55% | 0.94 | -0.06 | -6.79% |
| Q3 2023 Q2Q % growth | 1.15 202.63% | 0.71 | 0.44 | 62.28% |
| Q2 2023 Q2Q % growth | 0.65 66.67% | 0.57 | 0.08 | 13.74% |
| Q1 2023 Q2Q % growth | 0.62 31.91% | 0.48 | 0.14 | 27.86% |
| Q4 2022 Q2Q % growth | 0.73 73.81% | 0.41 | 0.32 | 76.19% |
| Q3 2022 Q2Q % growth | 0.38 -17.39% | 0.40 | -0.02 | -5.52% |
| Q2 2022 Q2Q % growth | 0.39 85.71% | 0.35 | 0.04 | 9.87% |
| Q1 2022 Q2Q % growth | 0.47 74.07% | 0.37 | 0.10 | 28.00% |
| Q4 2021 Q2Q % growth | 0.42 162.50% | 0.37 | 0.05 | 13.85% |
| Q3 2021 Q2Q % growth | 0.46 206.67% | 0.25 | 0.21 | 85.34% |
| Q2 2021 Q2Q % growth | 0.21 31.25% | 0.21 | 0.00 | -1.17% |
| Q1 2021 Q2Q % growth | 0.27 58.82% | 0.19 | 0.08 | 43.64% |
| Q4 2020 Q2Q % growth | 0.16 128.57% | 0.14 | 0.02 | 14.38% |
| Q3 2020 Q2Q % growth | 0.15 50.00% | 0.14 | 0.01 | 4.72% |
| Q2 2020 Q2Q % growth | 0.16 100.00% | 0.14 | 0.02 | 15.59% |
| Q1 2020 Q2Q % growth | 0.17 70.00% | 0.09 | 0.08 | 93.80% |
| Q4 2019 Q2Q % growth | 0.07 | 0.08 | -0.01 | -7.47% |
| Q3 2019 Q2Q % growth | 0.10 | 0.07 | 0.03 | 46.70% |
| Q2 2019 Q2Q % growth | 0.08 | 0.03 | 0.05 | 129.53% |
| Q1 2019 Q2Q % growth | 0.10 | 0.04 | 0.06 | 145.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 174.414M -4.38% | 176.81M | -2.396M | -1.36% |
| Q1 2025 Q2Q % growth | 170.528M -0.76% | 174.78M | -4.252M | -2.43% |
| Q4 2024 Q2Q % growth | 186.523M 4.73% | 192.04M | -5.517M | -2.87% |
| Q3 2024 Q2Q % growth | 191.214M 5.90% | 198.59M | -7.376M | -3.71% |
| Q2 2024 Q2Q % growth | 182.394M 25.17% | 174.36M | 8.034M | 4.61% |
| Q1 2024 Q2Q % growth | 171.836M 22.72% | 177.51M | -5.674M | -3.20% |
| Q4 2023 Q2Q % growth | 178.105M 31.93% | 179M | -895K | -0.50% |
| Q3 2023 Q2Q % growth | 180.556M 50.34% | 178.12M | 2.436M | 1.37% |
| Q2 2023 Q2Q % growth | 145.712M 17.99% | 140.12M | 5.592M | 3.99% |
| Q1 2023 Q2Q % growth | 140.022M 16.30% | 136.85M | 3.172M | 2.32% |
| Q4 2022 Q2Q % growth | 135M 11.66% | 129.52M | 5.48M | 4.23% |
| Q3 2022 Q2Q % growth | 120.1M 7.04% | 128.9M | -8.8M | -6.83% |
| Q2 2022 Q2Q % growth | 123.5M 21.44% | 120.42M | 3.08M | 2.56% |
| Q1 2022 Q2Q % growth | 120.4M 16.89% | 115.97M | 4.43M | 3.82% |
| Q4 2021 Q2Q % growth | 120.9M 26.07% | 113.87M | 7.03M | 6.17% |
| Q3 2021 Q2Q % growth | 112.2M 34.53% | 105.31M | 6.89M | 6.54% |
| Q2 2021 Q2Q % growth | 101.7M 18.53% | 103.41M | -1.71M | -1.65% |
| Q1 2021 Q2Q % growth | 103M 21.61% | 99.207M | 3.793M | 3.82% |
| Q4 2020 Q2Q % growth | 95.9M 14.99% | 90.717M | 5.183M | 5.71% |
| Q3 2020 Q2Q % growth | 83.4M 4.12% | 93.088M | -9.688M | -10.41% |
| Q2 2020 Q2Q % growth | 85.8M 8.61% | 88.348M | -2.548M | -2.88% |
| Q1 2020 Q2Q % growth | 84.7M 6.14% | 84.631M | 69K | 0.08% |
| Q4 2019 Q2Q % growth | 83.4M | 83.425M | -25K | -0.03% |
| Q3 2019 Q2Q % growth | 80.1M | 80.104M | -4K | 0.00% |
| Q2 2019 Q2Q % growth | 79M | 79.166M | -166K | -0.21% |
| Q1 2019 Q2Q % growth | 79.8M | 77.724M | 2.076M | 2.67% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.15% | -15.64% | 6.38% | 6.07% |
| Revenue | -0.63% | -6.81% | 0.39% | 0.4% |